These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 20304183

  • 21. Analysis of risk factors for the development of posttransplant lymphoprolipherative disorder among 119 children who received primary intestinal transplants at a single center.
    Quintini C, Kato T, Gaynor JJ, Ueno T, Selvaggi G, Gordon P, McLaughlin G, Tompson J, Ruiz P, Tzakis A.
    Transplant Proc; 2006; 38(6):1755-8. PubMed ID: 16908272
    [Abstract] [Full Text] [Related]

  • 22. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC, Curtis JL, Szmuszkovicz JR, Horn MV, Ford HR, Woo MS, Wang KS.
    J Pediatr Surg; 2008 Dec; 43(12):2174-7. PubMed ID: 19040929
    [Abstract] [Full Text] [Related]

  • 23. Post-transplant lymphoproliferative disorders in liver transplant recipients: a clinicopathological study.
    Lo RC, Chan SC, Chan KL, Chiang AK, Lo CM, Ng IO.
    J Clin Pathol; 2013 May; 66(5):392-8. PubMed ID: 23423516
    [Abstract] [Full Text] [Related]

  • 24. Liver transplantation at the University of Chicago.
    Millis JM, Alonso EM, Piper JB, Bruce DS, Newell KA, Woodle ES, Baker AL, Whitington PF, Thistlethwaite JR.
    Clin Transpl; 1995 May; ():187-97. PubMed ID: 8794265
    [Abstract] [Full Text] [Related]

  • 25. Slc11a1 (formerly Nramp1) polymorphisms and susceptibility to post-transplant lymphoproliferative disease following pediatric liver transplantation.
    Barshes NR, Lee TR, Goss JA, Goodpastor SE, Huls MH, Rooney CM, Karpen SJ, Wyllie S.
    Transpl Infect Dis; 2006 Jun; 8(2):108-12. PubMed ID: 16734634
    [Abstract] [Full Text] [Related]

  • 26. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.
    Zangwill SD, Hsu DT, Kichuk MR, Garvin JH, Stolar CJ, Haddad J, Stylianos S, Michler RE, Chadburn A, Knowles DM, Addonizio LJ.
    J Heart Lung Transplant; 1998 Dec; 17(12):1161-6. PubMed ID: 9883755
    [Abstract] [Full Text] [Related]

  • 27. Quantitative Epstein-Barr virus viral load monitoring in pediatric liver transplantation.
    Jang JY, Kim KM, Lee YJ, Lee SG, Chi HS.
    Transplant Proc; 2008 Oct; 40(8):2546-8. PubMed ID: 18929796
    [Abstract] [Full Text] [Related]

  • 28. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E, Cooperative Study Group on PTLDs.
    Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
    [Abstract] [Full Text] [Related]

  • 29. Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia.
    Kim JM, Lee SK, Kim SJ, Joh JW, Kwon CH, Choe YH, Shin M, Kim EY, Moon JI, Jung GO, Choi GS.
    Transplant Proc; 2010 Apr; 42(3):895-9. PubMed ID: 20430199
    [Abstract] [Full Text] [Related]

  • 30. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
    Walker RC, Paya CV, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, Daly RC, McGregor CG.
    J Heart Lung Transplant; 1995 Apr; 14(2):214-21. PubMed ID: 7779838
    [Abstract] [Full Text] [Related]

  • 31. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 32. Post-transplant lymphoproliferative disorder after pediatric liver transplantation: characteristics and outcome.
    Fernández MC, Bes D, De Dávila M, López S, Cambaceres C, Dip M, Imventarza O.
    Pediatr Transplant; 2009 May; 13(3):307-10. PubMed ID: 18346039
    [Abstract] [Full Text] [Related]

  • 33. Long-term survival after post-transplant lymphoproliferative disease in children.
    Nathanson S, Debray D, Delarue A, Deschênes G.
    Pediatr Nephrol; 2002 Aug; 17(8):668-72. PubMed ID: 12185479
    [Abstract] [Full Text] [Related]

  • 34. The role of valacyclovir on Epstein-Barr virus viral loads in pediatric liver transplantation patients.
    Ozçay F, Arslan H, Bilezikçi B, Sevmiş S, Moray G, Haberal M.
    Transplant Proc; 2009 Sep; 41(7):2878-80. PubMed ID: 19765462
    [Abstract] [Full Text] [Related]

  • 35. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD.
    D'Antiga L, Del Rizzo M, Mengoli C, Cillo U, Guariso G, Zancan L.
    Liver Transpl; 2007 Mar; 13(3):343-8. PubMed ID: 17154402
    [Abstract] [Full Text] [Related]

  • 36. Decreasing incidence of symptomatic Epstein-Barr virus disease and posttransplant lymphoproliferative disorder in pediatric liver transplant recipients: report of the studies of pediatric liver transplantation experience.
    Narkewicz MR, Green M, Dunn S, Millis M, McDiarmid S, Mazariegos G, Anand R, Yin W, Studies of Pediatric Liver Transplantation Research Group.
    Liver Transpl; 2013 Jul; 19(7):730-40. PubMed ID: 23696264
    [Abstract] [Full Text] [Related]

  • 37. Pediatric liver transplantation for biliary atresia: results of primary grafts in 328 recipients.
    Diem HV, Evrard V, Vinh HT, Sokal EM, Janssen M, Otte JB, Reding R.
    Transplantation; 2003 May 27; 75(10):1692-7. PubMed ID: 12777858
    [Abstract] [Full Text] [Related]

  • 38. Outcomes of 5-year survivors of pediatric liver transplantation: report on 461 children from a north american multicenter registry.
    Ng VL, Fecteau A, Shepherd R, Magee J, Bucuvalas J, Alonso E, McDiarmid S, Cohen G, Anand R, Studies of Pediatric Liver Transplantation Research Group.
    Pediatrics; 2008 Dec 27; 122(6):e1128-35. PubMed ID: 19047213
    [Abstract] [Full Text] [Related]

  • 39. Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma.
    Jiménez-Rivera C, Avitzur Y, Fecteau AH, Jones N, Grant D, Ng VL.
    Pediatr Transplant; 2004 Jun 27; 8(3):243-8. PubMed ID: 15176961
    [Abstract] [Full Text] [Related]

  • 40. Long-term survival expectancy after liver transplantation in children.
    Migliazza L, López Santamaría M, Murcia J, Gamez M, Clavijo J, Camarena C, Hierro L, Frauca E, de la Vega A, Diaz M, Jara P, Tovar JA.
    J Pediatr Surg; 2000 Jan 27; 35(1):5-7; discussion 7-8. PubMed ID: 10646764
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.